Works matching DE "TYPE I interferons"


Results: 3242
    1
    2

    HIGHLIGHTED ARTICLES.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 118, n. 2, p. 288, doi. 10.1002/cpt.3742
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Type I Interferons in SARS-CoV-2 Cutaneous Infection: Is There a Role in Antiviral Defense?

    Published in:
    International Journal of Molecular Sciences, 2025, v. 26, n. 13, p. 6049, doi. 10.3390/ijms26136049
    By:
    • Yendo, Tatiana Mina;
    • Orfali, Raquel Leão;
    • Pereira, Naiura Vieira;
    • Pereira, Natalli Zanete;
    • Ramos, Yasmim Álefe Leuzzi;
    • Kawakami, Joyce Tiyeko;
    • Duarte-Neto, Amaro Nunes;
    • Sotto, Mirian Nacagami;
    • Silva, Luiz Fernando Ferraz;
    • Duarte, Alberto José da Silva;
    • Sato, Maria Notomi;
    • Aoki, Valeria
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16

    Early NK-cell and T-cell dysfunction marks progression to severe dengue in patients with obesity and healthy weight.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60941-9
    By:
    • Gregorova, Michaela;
    • Santopaolo, Marianna;
    • Garner, Lucy C.;
    • Hayati, Rahma F.;
    • Diamond, Divya;
    • Ramamurthy, Narayan;
    • Tran, Vi Thuy;
    • Nguyen, Nguyet Minh;
    • Heesom, Kate J.;
    • Nguyen, Vuong Lam;
    • Jones, Eben;
    • Nsubuga, Mike;
    • Luscombe, Curtis;
    • Vo, Hoa Thi My;
    • Ho, Chanh Quang;
    • Nguyen, Chau Thi Xuan;
    • Dong, Tam Thi Hoai;
    • Huynh, Duyen Thi Le;
    • Cao, Tam Thi;
    • Davidson, Andrew D.
    Publication type:
    Article
    17
    18
    19
    20

    Peran Anifrolumab dan Belimab pada Sle.

    Published in:
    Cerdika : Jurnal Ilmiah Indonesia, 2025, v. 5, n. 6, p. 1759, doi. 10.59141/cerdika.v5i6.2669
    By:
    • Rani Juli Antari, Ni Komang
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    45
    46
    47
    48

    Disease activity and glucocorticoid tapering patterns in Japanese patients with systemic lupus erythematosus treated with anifrolumab: Post hoc analysis of the Japanese subpopulation of the TULIP-2 study.

    Published in:
    Modern Rheumatology, 2025, v. 35, n. 3, p. 470, doi. 10.1093/mr/roae105
    By:
    • Tanaka, Yoshiya;
    • Atsumi, Tatsuya;
    • Okada, Masato;
    • Miyamura, Tomoya;
    • Ishii, Tomonori;
    • Nishiyama, Susumu;
    • Matsumura, Ryutaro;
    • Morishima, Yosuke;
    • Yamaguchi, Yoshiyuki;
    • Abreu, Gabriel;
    • Lindholm, Catharina;
    • Morand, Eric F;
    • Takeuchi, Tsutomu
    Publication type:
    Article
    49

    Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumab.

    Published in:
    Modern Rheumatology, 2024, v. 34, n. 6, p. 1281, doi. 10.1093/mr/roae038
    By:
    • Umeda, Masataka;
    • Kojima, Kanako;
    • Michitsuji, Toru;
    • Tsuji, Yoshika;
    • Shimizu, Toshimasa;
    • Fukui, Shoichi;
    • Sumiyoshi, Remi;
    • Koga, Tomohiro;
    • Kawashiri, Shin-ya;
    • Naoki, Iwamoto;
    • Iagawa, Takashi;
    • Tamai, Mami;
    • Origuchi, Tomoki;
    • Furuyama, Masako;
    • Tsuboi, Masahiko;
    • Matsuoka, Naoki;
    • Okada, Akitomo;
    • Aramaki, Toshiyuki;
    • Kawakami, Atsushi
    Publication type:
    Article
    50